Pharmaceutical Fine Chemicals Market Report

Pharmaceutical Fine Chemicals Market Analysis By Application (Cardiovascular, Neurological, Oncological, Diabetes, Respiratory, Gastrointestinal, Musculoskeletal), By Type, By Size, And Segment Forecasts, 2018 - 2025

  • Published Date: Aug, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-978-4
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 122

Market Segmentation

  • Application Outlook (Revenue, USD Billion, 2014 - 2025)
    • Cardiovascular
    • Neurology
    • Oncology
    • Infectious diseases
    • Metabolic system
    • Diabetes
    • Respiratory disease
    • Gastrointestinal diseases
    • Musculoskeletal diseases
    • Others
  • Type Outlook (Revenue, USD Billion, 2014 - 2025)
    • Proprietary
    • Non-proprietary
  • Size Outlook (Revenue, USD Billion, 2014 - 2025)
    • Small molecules
    • Big molecules
  • Product Outlook (Revenue, USD Billion, 2014 - 2025)
    • Basic building blocks
    • Advanced intermediates
    • Active ingredients
  • Regional Outlook (Revenue, USD Billion, 2014 - 2025)
    • North America
      • North America Pharmaceutical fine chemical market, by application
        • Cardiovascular
        • Neurology
        • Oncology
        • Infectious diseases
        • Metabolic system
        • Diabetes
        • Respiratory disease
        • Gastrointestinal diseases
        • Musculoskeletal diseases
        • Others
      • North America Pharmaceutical fine chemical market, by type
        • Proprietary
        • Non-proprietary
      • North America Pharmaceutical fine chemical market, by size
        • Small molecules
        • Big molecules
      • North America Pharmaceutical fine chemical market, by product
        • Basic building blocks
        • Advanced intermediates
        • Active ingredients
      • U.S.
        • U.S. Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • U.S. Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • U.S. Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • U.S. Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
    • Europe
      • Europe Pharmaceutical fine chemical market, by application
        • Cardiovascular
        • Neurology
        • Oncology
        • Infectious diseases
        • Metabolic system
        • Diabetes
        • Respiratory disease
        • Gastrointestinal diseases
        • Musculoskeletal diseases
        • Others
      • Europe Pharmaceutical fine chemical market, by type
        • Proprietary
        • Non-proprietary
      • Europe Pharmaceutical fine chemical market, by size
        • Small molecules
        • Big molecules
      • Europe Pharmaceutical fine chemical market, by product
        • Basic building blocks
        • Advanced intermediates
        • Active ingredients
      • Germany
        • Germany Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • Germany Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • Germany Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • Germany Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
      • UK
        • UK Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • UK Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • UK Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • UK Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
    • Asia Pacific
      • Asia Pacific Pharmaceutical fine chemical market, by application
        • Cardiovascular
        • Neurology
        • Oncology
        • Infectious diseases
        • Metabolic system
        • Diabetes
        • Respiratory disease
        • Gastrointestinal diseases
        • Musculoskeletal diseases
        • Others
      • Asia Pacific Pharmaceutical fine chemical market, by type
        • Proprietary
        • Non-proprietary
      • Asia Pacific Pharmaceutical fine chemical market, by size
        • Small molecules
        • Big molecules
      • Asia Pacific Pharmaceutical fine chemical market, by product
        • Basic building blocks
        • Advanced intermediates
        • Active ingredients
      • China
        • China Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • China Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • China Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • China Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
      • Japan
        • Japan Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • Japan Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • Japan Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • Japan Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
      • India
        • India Pharmaceutical fine chemical market, by application
          • Cardiovascular
          • Neurology
          • Oncology
          • Infectious diseases
          • Metabolic system
          • Diabetes
          • Respiratory disease
          • Gastrointestinal diseases
          • Musculoskeletal diseases
          • Others
        • India Pharmaceutical fine chemical market, by type
          • Proprietary
          • Non-proprietary
        • India Pharmaceutical fine chemical market, by size
          • Small molecules
          • Big molecules
        • India Pharmaceutical fine chemical market, by product
          • Basic building blocks
          • Advanced intermediates
          • Active ingredients
    • Central & South America (CSA)
      • CSA Pharmaceutical fine chemical market, by application
        • Cardiovascular
        • Neurology
        • Oncology
        • Infectious diseases
        • Metabolic system
        • Diabetes
        • Respiratory disease
        • Gastrointestinal diseases
        • Musculoskeletal diseases
        • Others
      • CSA Pharmaceutical fine chemical market, by type
        • Proprietary
        • Non-proprietary
      • CSA Pharmaceutical fine chemical market, by size
        • Small molecules
        • Big molecules
      • CSA Pharmaceutical fine chemical market, by product
        • Basic building blocks
        • Advanced intermediates
        • Active ingredients
    • Middle East & Africa (MEA)
      • MEA Pharmaceutical fine chemical market, by application
        • Cardiovascular
        • Neurology
        • Oncology
        • Infectious diseases
        • Metabolic system
        • Diabetes
        • Respiratory disease
        • Gastrointestinal diseases
        • Musculoskeletal diseases
        • Others
      • MEA Pharmaceutical fine chemical market, by type
        • Proprietary
        • Non-proprietary
      • MEA Pharmaceutical fine chemical market, by size
        • Small molecules
        • Big molecules
      • MEA Pharmaceutical fine chemical market, by product
        • Basic building blocks
        • Advanced intermediates
        • Active ingredients

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.